Strattera Suicidal Thinking Data Is Of Little Clinical Significance, Lilly Consultants Say
This article was originally published in The Pink Sheet Daily
Executive Summary
Data analysis used as the basis for a public health advisory on Lilly’s Strattera in children and adolescents is unreliable, SUNY Upstate Medical University, Columbia University professors say.
You may also be interested in...
Strattera Cleared For Longer Use In ADHD Kids
Trial data could reassure doctors about treating as needed, Lilly says.
Strattera Cleared For Longer Use In ADHD Kids
Trial data could reassure doctors about treating as needed, Lilly says.
Shire/Noven Methypatch For ADHD To Be Reviewed By Psychopharm Committee
Companies seek indication for once-daily methylphenidate patch for the treatment of attention deficit/hyperactivity disorder in children ages six to 12 years.